tuberculosis

J&J Exec: Tuberculosis is a Global Emergency. It's Time to Start Treating it That Way

By Paul Stoffels
Summary: 
  • Ebola, and HIV before it, shows what can be accomplished once a disease is catapulted to the top of the global agenda.
     
  • Dr. Paul Stoffels, Johnson & Johnson's chief scientific officer, says tuberculosis is a far deadlier disease, but has not received this sort of attention and focus from the global community.
     
  • An outdated and inadequate toolbox is largely to blame for the unacceptably high toll of TB.
Article
  • Ebola, and HIV before it, shows what can be accomplished once a disease is catapulted to the top of the global agenda.
     
  • Dr. Paul Stoffels, Johnson & Johnson's chief scientific officer, says tuberculosis is a far deadlier disease, but has not received this sort of attention and focus from the global community.
     
  • An outdated and inadequate toolbox is largely to blame for the unacceptably high toll of TB.

Lilly: Announcing the 2015 REACH Lilly MDR TB Partnership Media Award Winners

Blog

Today’s guest blog comes from Sunita Prasad, senior manager for Lilly’s MDR-TB Partnership in India.

Tuberculosis (TB) continues to pose a monumental global health challenge. The disease affected nine million people in 2013, and claimed 1.5 million lives. In India, 1,000 people die of TB daily, though the disease is fully curable.

Lilly: Forging Alliances is Crucial to Fighting Tuberculosis

Blog

Today’s guest Blogger is Dr. Lasha Goguadze, Senior Health Officer, Global Tuberculosis Programme, International Federation of the Red Cross and Red Crescent Societies. He is based in Geneva.

Healthcare Breakthrough: Innovation Coalition Supports 'Last Mile' Of Care In Underserved Regions

By Susan Galer, SAP
Article

In Uganda, the donation of a simple mosquito net can mean the difference between life and death to the family of Sarah Namugosa, a pregnant woman recently recovered from Malaria.

SAP on the Frontline Against Infectious Disease

Multimedia with summary

Decades ago, many believed the fight against infectious diseases had been won. But diseases like HIV-AIDS have emerged and become epidemics. Malaria and tuberculosis still persist, impacting the lives of millions of children worldwide annually. And newer threats like Ebola have taken center stage. Around the world, SAP is developing technology solutions and teaming with organizations to fight these diseases. See how SAP used SAP HANA cloud platform and other innovations to help contain Ebola.

Lilly: Taking the Fight to MDR-TB

Blog

Today's guest blog comes from Lilly's vice president of Global Health Programs, Evan Lee, M.D.

“Americans can no longer afford to be indifferent to the rise of drug-resistant tuberculosis.”

Lilly: Renewed Awakening to the Global TB Crisis

Blog

Today's guest blog comes from Lilly's vice president of Global Health Programs, Evan Lee, M.D.

Having recently returned from the annual Union World Conference on Lung Health, I am struck by the signs of increased solidarity and urgency in the fight against tuberculosis (TB). As a physician, I can’t help but see parallels between the disease we are fighting and the promise of increased momentum in national and international efforts.

SAP Helps Fight AIDS, Tuberculosis and Malaria in Africa

Article

The Global Fund is an international financing organisation started in 2002 to fight AIDS, tuberculosis (TB) and malaria.

SAP today announced that in addition to committing $4 million over a period of four years to the Global Fund, through its partnership with (RED), SAP technology is helping the organisation more simply understand how its financial investments are being used for disease prevention and treatment.

SAP Innovation Helps The Global Fund Fight AIDS, Tuberculosis and Malaria in Africa

Extending Longstanding Partnership, SAP is Founding Member of The Global Fund’s New Coalition Uniting Private Sector to Support Disease Prevention and Treatment Efforts
Press Release

WALLDORF, Germany, Sept. 24, 2014 /3BL Media/ — The Global Fund is an international financing organization started in 2002 to fight AIDS, tuberculosis (TB) and malaria. SAP SE (NYSE: SAP) today announced that SAP technology is helping the organization more simply understand how its financial investments are being used for disease prevention and treatment.

Pages

Subscribe to tuberculosis